Skin Therapy Letter-Family Practice Edition | |
Interleukin-23 in the Pathogenesis and Treatment of Psoriasis | |
关键词: cytokine; interleukin-23; IL-23; guselkumab; tildrakizumab; Th17; psoriasis; | |
DOI : | |
学科分类:医学(综合) | |
来源: Skin Therapy Letter-Family Practice Edition | |
【 摘 要 】
In the past three decades, major advances have been made in understanding the pathogenesis of psoriasis. The currently accepted theory is that T-cell mediated immune dysregulation triggers keratinocyte hyperproliferation in psoriasis. Recent research indicates that the Th17/interleukin (IL)-23 pathway plays a prominent role in the amplification phase of psoriasis. The discovery of the Th17/ IL-23 pathway provides targets for new drug development. This review focuses on the role of IL-23 in psoriasis pathogenesis and the current therapies targeting IL-23 that are in clinical trials.
【 授权许可】
Unknown
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201912040572961ZK.pdf | 590KB | download |